Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 1Hematologic Neoplasms 1Anemia 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × ferrous succinate × Clear all
NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Zhongnan Hospital

Phase 3 Unknown
168 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
70 enrolled
Classical hematologyLymphoid

Anemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡